請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33928完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林仁混(Jen-Kun Lin) | |
| dc.contributor.author | Kuan-Hung Chen | en |
| dc.contributor.author | 陳冠宏 | zh_TW |
| dc.date.accessioned | 2021-06-13T05:49:15Z | - |
| dc.date.available | 2008-08-04 | |
| dc.date.copyright | 2006-08-04 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-07-09 | |
| dc.identifier.citation | 1.Hirsch FR, Lippman SM. Advances in the biology of lung cancer chemoprevention. J Clin Oncol. 2005;23:3186-3197.
2.Brown JR, DuBois RN. Cyclooxygenase as a target in lung cancer. Clin Cancer Res. 2004;10:4266-4269. 3.Kim ES, Hong WK, Khuri FR. Prevention of lung cancer. The new millennium. Chest Surg Clin North Am. 2000;10:663–690. 4.Cancer facts and Figures 2000. American Cancer Society 2000 Atlanta, GA, http:// www.cancer.org/dowloads/STT/ F&F00.pdf. 5.Petkova DK, Clelland C, Ronan J, Pang L, Coulson JM, Lewis S, Knox AJ. Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir Med. 2004; 98:164-172. 6.Sjodahl R. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects. Am J Med. 2001;110:66–69. 7.Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, Feng L, Hong WK, Xu XC. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res. 2001;7:861–867. 8.Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97–120. 9.Chandrasekharan, N. V., Dai, H., Roos, K. L., Evanson, N. K., Tomsik, J., Elton, T. S. & Simmons, D. L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/ antipyretic drugs: Cloning, structure, and expression. Proc. Natl. Acad. Sci. 2002;99:13926–13931. 10.Koki A, Khan NK, Woerner BM, Dannenberg AJ, Olson L, Seibert K, Edwards D, Hardy M, Isakson P, Masferrer JL. Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol. 2002;507:177–184. 11.Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998;58:3761–3764. 12.Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y, Ochiai A. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer. 2000;30:73–81. 13.Anderson WF, Umar A, Viner JL, Hawk ET. The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm. 2002;8:1035–1062. 14.Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998;58:4997–5001. 15.Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and downregulation of interleukin 12 production. Cancer Res. 1998;58:1208–1216. 16.Fang HY, Lin TS, Lin JP, Wu YC, Chow KC, Wang LS. Cyclooxygenase-2 in human nonsmall cell lung cancer. Eur J Surg Oncol. 2003;29:171–177. 17.Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T, Takahashi T. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res. 1999;5:1001–1005. 18.Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Holscher AH, Danenberg KD, Danenberg PV. Prognostic significance of cyclooxygenase 2 mRNA expression in non- small cell lung cancer. Ann Surg.. 2002;235:440–443. 19.Barnes PJ. Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med. 1994;150(5 Pt 2):42-49. 20.Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol. 1991;87(4):794-802. 21.Tsukagoshi H, Sakamoto T, Xu W, Barnes PJ, Chung KF. Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J Allergy Clin Immunol. 1994;93(2):464-469. 22.Belvisi MG, Saunders MA, Haddad el-B, Hirst SJ, Yacoub MH, Barnes PJ, Mitchell JA. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol. 1997;120(5):910-916. 23.Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992;267(36):25934-25938. 24.Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994;93(1):391-396. 25.Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095- 2147. 26.Jang BC, Lim KJ, Paik JH, Kwon YK, Shin SW, Kim SC, Jung TY, Kwon TK, Cho JW, Baek WK, Kim SP, Suh MH, Suh SI. Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. Biochem Biophys Res Commun. 2004;320(3):1026-1033. 27.Chen P, Cai Y, Yang ZG, Zhou R, Zhang GS, Domann F, Fang X. Involvement of PKC, p38 MAPK and AP-2 in IL-1beta-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells. Respirology. 2006;11(1):18-23. 28.Attaway JA. Citrus juice flavonoids with anticarcinogenic and antitumor properties, In Food Pytochemicals for Cancer Prevention I. Huang,M.T., Osawa,T., Ho,C.T. and Rosen,R.T. (Eds). American Chemical Society, Washington, DC, 1994;240–248. 29.Stavric,B. Antimutagens and anticarcinogens in foods. Food Chem. Toxicol. 1994; 32:79–90. 30.Wattenberg LW. Chemoprevention of cancer. Cancer Res. 1985;45: 1–8. 31.Wattenberg LW. Inhibition of carcinogenesis by minor anutrient constituents of the diet. Proc. Nutr. Soc. 1990;49:173–183. 32.Murakami A, Nakamura Y, Torikai K, Tanaka T, Koshiba T, Koshimizu K, Kuwahara S, Takahashi Y, Ogawa K, Yano M, Tokuda H, Nishino H, Mimaki Y, Sashida Y, Kitanaka S, Ohigashi H. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 2000;60(18):5059-5066. 33.Bracke M, Bruyneel EA, Vermeulen SJ, Vennekens K, Marck VV. and Mareel MM. Citrus flavonoid effect on tumor invasion and metastasis. Food Technol. 1994; 48: 121–142. 34.Hirano T, Abe K, Gotoh M, Oka K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer. 1995;72(6):1380-1388. 35.Nelson EK. The occurrence of pentamethyl flavonol in tangerine peel. J. Am. Chem. Soc. 1934;56:1392–1393. 36.Ben-Aziz A. Nobiletin is main fungistat in tangerines resistant to mal secco. Science. 1967;155:1026–1027. 37.So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer. 1996;26(2):167-181. 38.Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf. 1998;18(4):251-272. 39.Chaumontet C, Bex V, Gaillard-Sanchez I, Seillan-Heberden C, Suschetet M, Martel P. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis. 1994;15(10):2325-2330. 40.Chaumontet C, Droumaguet C, Bex V, Heberden C, Gaillard-Sanchez I, Martel P. Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. Cancer Lett. 1997;114 (1-2):207-210. 41.Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem. 1999; 63(5) :896-899. 42.Pan MH, Chen WJ, Lin-Shiau SY, Ho CT, Lin JK. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis. 2002;23(10):1677-1684. 43.Apte RN, Voronov E. Interleukin-1--a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol. 2002;12(4):277-290 44.Lin YL, Juan IM, Chen YL, Liang YC, and Lin JK. Composition of polyphenols in fresh tea leaves and associations of their oxygen-radicalabsorbing capacity with antiproliferative actions in fibroblast cells. J. Agric. Food. Chem. 1996;44: 1387–1394. 45.Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 2000;60(14):3823-3831. 46.Wang IK, Lin-Shiau SY, Lin JK. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer. 1999 Oct;35(10):1517-1525. 47.Nieminen R, Leinonen S, Lahti A, Vuolteenaho K, Jalonen U, Kankaanranta H, Goldring MB, Moilanen E. Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes. Mediators Inflamm. 2005; 2005(5):249-255. 48.Rosch S, Ramer R, Brune K, Hinz B. Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases. Biochem Biophys Res Commun. 2005;338(2):1171-1178. 49.Cho JW, Park K, Kweon GR, Jang BC, Baek WK, Suh MH, Kim CW, Lee KS, Suh SI. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med. 2005;37(3):186-192. 50.Lin CH, Sheu SY, Lee HM, Ho YS, Lee WS, Ko WC, Sheu JR. Involvement of protein kinase C-gamma in IL-1beta-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Mol Pharmacol. 2000;57(1):36-43. 51.Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol. 2004;173(3):2011-2022. 52.Shishodia S, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res. 2004;64(14):5004-5012. 53.Petkova DK, Clelland C, Ronan J, Pang L, Coulson JM, Lewis S, Knox AJ. Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir Med. 2004;98(2):164-172. 54.Jang MH, Shin MC, Lim S, Han SM, Park HJ, Shin I, Lee JS, Kim KA, Kim EH, Kim CJ. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J. Pharmacol Sci. 2003; 91(2):95-104. 55.Silalahi J. Anticancer and health protective properties of citrus fruit components. Asia Pac J Clin Nutr. 2002;11(1):79-84. 56.Chen,J., Montanari,A.M. and Widmer,W.W. Two new polymethoxylated flavonoids, a class of compounds with potential anticancer activity, isolated from cold pressed Dancy tangerine peel oil solids. J. Agric. Food Chem. 1997;45, 364–368. 57.Sugiyama,S., Umemura,K., Kuroyanagi,M., Ueno,A. and Taki,T. Studies on the differentiation inducers of myeloid leukemic cells from Citrus species. Chem. Pharm. Bull. 1993;41:714–719. 58.Kandawaswami,C., Perkins,E., Soloniuk,D.S., Drzewiecki,G. and Middleton,E.,Jr. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett. 1991;56:147–152. 59.Wall,M.W., Wani,M.C., Manukumar,G., Abraham,P., Taylor,H., Hughes,T.J., Warner,J. and McGivney,R. Plant antimutagenic agents, 2 Flavonoids. J. Nat. Prod. (Lloydia). 1998;51:1084–1091. 60.Ishiwa,J., Sato,T., Mimaki,Y., Sashida,Y., Yano,M. and Ito,A.A. Citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J. Rheumatol., 2000;27:20–25. 61.Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, Yano M, Ito A. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol. 2003;65(12): 2065-2071. 62.Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol. 1999;19(7):4798-4805. 63.Teshima S, Nakanishi H, Nishizawa M, Kitagawa K, Kaibori M, Yamada M, Habara K, Kwon AH, Kamiyama Y, Ito S, Okumura T. Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J Hepatol. 2004;40(4):616-623. 64.Reddy SA, Huang JH, Liao WS. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem. 1997;272(46):29167-29173. 65.Grimm S, Baeuerle PA. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J. 1993;290(Pt 2):297-308. 66.Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141-179. 67.Ogasawara A, Arakawa T, Kaneda T, Takuma T, Sato T, Kaneko H, Kumegawa M, Hakeda Y. Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP beta, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J Biol Chem. 2001;276(10):7048-7054. 68.Bazan NG, Lukiw WJ. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem. 2002;277(33):30359-30367. 69.Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R, Karin M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 1994;14(10):6683-6688. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33928 | - |
| dc.description.abstract | Tangeretin 為柑橘類果皮中含量最豐富的多甲氧基類黃酮 ( polymethoxylated flavonoid )。 在近幾年的研究中， tangeretin 已被發現具有抗細胞生長、抗癌細胞侵襲與轉移、以及抗氧化的功能。 然而在抗發炎部分的研究則不甚明瞭。 在本篇論文中，我們研究 tangeretin 及其構造相似物 nobiletin 對發炎反應高度相關的環氧化酵素(Cyclooxygenase-2 ,COX-2 )表現的調控。我們使用的細胞為 : 肺癌上皮細胞( A549 ) 和非小細胞型肺癌細胞 (H1299)。實驗結果發現，不論是tangeretin 或 nobiletin 都能有效抑制介白素-1β (IL-1β) 所引發的 COX-2 表現，而且 tangeretin 的抑制效果明顯優於 nobiletin。 同時我們發現 tangeretin 對抑制細胞內生性 COX-2 的表現也有同樣的效果。進一步的研究也看到tangeretin 能有效抑制 IL-1β 活化的細胞激酶 : p38、JNK、AKT，並且可藉由抑制 IL-1β 活化 p38 及 AKT 而調控轉錄因子 NF-kappaB 的活化，進一步達到抑制 COX-2 的效果。綜合我們的研究結果，我們推測 tangeretin 藉由抑制 p38 及 AKT 等激酶的活性，進而抑制轉錄因子 NF-kappaB 的活化，使得 COX-2 基因的轉錄受到部份抑制，最後造成肺癌細胞中 COX-2 蛋白表現量的下降。 | zh_TW |
| dc.description.abstract | Tangeretin (5,6,7,8,4’-pentamethoxyflavone) is a polymethoxylated flavonoid concentrated in the peel of citrus fruits. Recent studies have shown that tangeretin exhibits anti-proliferative, anti-invasive, anti-metastatic, and antioxidant activities. However, the anti-inflammatory properties of tangeretin are unclear. In this study, we examine the effects of tangeretin and its structure-related compound, nobiletin, on the expression of cyclooxygenases-2 (COX-2) in human lung epithelial carcinoma cells, A549, and human non-small cell lung carcinoma cells, H1299. Tangeretin exerts a much better inhibitory activity than nobiletin against IL-1beta-induced production of COX-2 in A549 cells, and it effectively represses the constitutively-expressed COX-2 in H1299. RT-PCR was used to investigate the transcriptional inhibition of COX-2 by tangeretin. COX-2 mRNA was rapidly induced by IL-1β in 3 h and markedly suppressed by tangeretin. IL-1β induced the activation of ERK, p38 MAPK, JNK, and AKT in A549 cells. COX-2 expression in response to IL-1beta was attenuated by pretreatment with SB203580, SP600125, and LY294002, but not with PD98059, suggesting the involvement of p38 MAPK, JNK, and PI3K in this response. Pretreatment of cells with tangeretin inhibited IL-beta-induced p38 MAPK, JNK, and AKT phosphorylation and the downstream activation of NF-kappaB. These results may reveal that the tangeretin inhibition of IL-1beta-induced COX-2 expression in A549 cells is, at least in part, mediated through suppression of NF-lappaB transcription factor as well as through suppression of the signaling proteins of p38 MAPK, JNK, and PI3K, but not of ERK. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T05:49:15Z (GMT). No. of bitstreams: 1 ntu-95-R93442020-1.pdf: 1300134 bytes, checksum: 12c088f6a1f1056b67ce5612c136c203 (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | Abstract in Chinese …………………………………………………1
Abstract…………………………………………………………………2 Introduction……………………………………………………………3 Materials and Methods ………………………………………………7 Results…………………………………………………………………11 Discussion ……………………………………………………………16 References ……………………………………………………………21 Figures and Tables …………………………………………………31 | |
| dc.language.iso | en | |
| dc.subject | 肺癌 | zh_TW |
| dc.subject | 環氧化酵素 | zh_TW |
| dc.subject | 多甲氧基類黃酮 | zh_TW |
| dc.subject | IL-1β | en |
| dc.subject | MAPKs | en |
| dc.subject | COX-2 | en |
| dc.subject | Tangeretin | en |
| dc.title | Tangeretin 抑制IL-1β誘發肺癌環氧化酵素(COX-2)表現之機制探討 | zh_TW |
| dc.title | Studies on the Inhibition of Interleukin-1β-induced Cyclooxygenase-2 Expression by Tangeretin in Human Lung Carcinoma Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 張明富(Ming-Fu Chang),何元順(Yuan-Soon Ho),梁有志(Yu-Chih Liang),蕭水銀(Shoei-Yn Shiau) | |
| dc.subject.keyword | 肺癌,環氧化酵素,多甲氧基類黃酮, | zh_TW |
| dc.subject.keyword | Tangeretin,IL-1β,COX-2,MAPKs, | en |
| dc.relation.page | 40 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2006-07-10 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
| 顯示於系所單位： | 生物化學暨分子生物學科研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-95-1.pdf 未授權公開取用 | 1.27 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。